tiprankstipranks
Trending News
More News >
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market
Advertisement

Citius Oncology (CTOR) Technical Analysis

Compare
118 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Citius Oncology’s (CTOR) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Citius Oncology is a Buy.
Citius Oncology’s (CTOR) 20-Day exponential moving average is 1.81, while Citius Oncology’s (CTOR) share price is $1.79, making it a Sell.
Citius Oncology’s (CTOR) 50-Day exponential moving average is 1.87, while Citius Oncology’s (CTOR) share price is $1.79, making it a Sell.

Citius Oncology (CTOR) Pivot Points

Oct 21, 2025, 09:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.52
1.59
1.65
1.72
1.78
1.85
1.91
Fibonacci
1.59
1.64
1.67
1.72
1.77
1.80
1.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Oncology (CTOR) Moving Averages

Oct 21, 2025, 09:13 PM
Period
Simple
Exponential
MA5
1.74Buy
1.76Buy
MA10
1.77Buy
1.78Buy
MA20
1.84Sell
1.81Sell
MA50
1.84Sell
1.87Sell
MA100
2.05Sell
1.82Sell
MA200
1.50Buy
1.53Buy
Citius Oncology’s (CTOR) 10-Day exponential moving average is 1.78, while Citius Oncology’s (CTOR) share price is $1.79, making it a Buy.
Citius Oncology’s (CTOR) 100-Day exponential moving average is 1.82, while Citius Oncology’s (CTOR) share price is $1.79, making it a Sell.
Citius Oncology’s (CTOR) stock price is $1.79 and Citius Oncology’s (CTOR) 50-day simple moving average is 1.84, creating a Sell signal.
Citius Oncology’s (CTOR) stock price is $1.79 and Citius Oncology’s (CTOR) 100-day simple moving average is 2.05, creating a Sell signal.
Citius Oncology’s (CTOR) stock price is $1.79 and Citius Oncology’s (CTOR) 200-day simple moving average is 1.50, creating a Buy signal.

Citius Oncology (CTOR) Technical Indicators

Oct 21, 2025, 09:13 PM
Name
Value
Implied Action
RSI (14)
47.31
Neutral
STOCH (9,6)
15.05
Buy
STOCHRSI (14)
15.05
Buy
MACD (12,26)
-0.04
Buy
ADX (14)
18.74
Buy
Williams %R
-79.31
Buy
CCI (14)
-42.31
Neutral
ATR (14)
0.18
-
Ultimate Oscillator
22.95
Sell
ROC
-11.82
Sell
Citius Oncology’s (CTOR) Relative Strength Index (RSI) is 47.31, creating a Neutral signal.
Citius Oncology’s (CTOR) Trend Strength Indicator (ADX) is 18.74, creating a Buy signal.
Citius Oncology’s (CTOR) Commodity Channel Index (CCI) is -42.31, creating a Neutral signal.
Citius Oncology’s (CTOR) Price Rate of Change (ROC) is -11.82, creating a Sell signal.

FAQ

Is CTOR a Buy, Hold, or Sell?
Based on CTOR’s technical indicators, CTOR is a Buy.
    What is CTOR’s RSI (14)?
    CTOR’s RSI (14) is 47.31, which suggests CTOR is a Neutral.
      What is CTOR’s MACD?
      CTOR’s MACD is -0.04, which suggests CTOR is a Buy.
        What is CTOR’s 5-day moving average?
        CTOR’s 5-day moving average is 1.74, which suggests CTOR is a Buy.
          What is CTOR’s 20-day moving average?
          CTOR 20-day moving average is 1.84, which suggests CTOR is a Sell.
            What is CTOR’s 50-day moving average?
            CTOR’s 50-day moving average is 1.84, which suggests CTOR is a Sell.
              What is CTOR’s 200-day moving average?
              CTOR’s 200-day moving average is 1.50, which suggests CTOR is a Buy.
                What is CTOR’s Williams % R (14)?
                CTOR’s Williams % R (14) is -79.31, which suggests CTOR is a Buy.
                  What is CTOR’s CCI (14)?
                  CTOR’s CCI (14) is -42.31, which suggests CTOR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis